Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 41-48

  Stahl, Sarah ^a,c   Chun, Tae Yon ^a   Gray, Wesley G ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SOUTHERN UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Estrogen receptor; Phytoestrogen; PR1 cells; Prolactin

Indexed keywords

COUMESTROL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GENISTEIN; PHYTOESTROGEN; PROLACTIN; RESVERATROL; ZEARALENONE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; HYPOPHYSIS TUMOR; NONHUMAN; PROLACTIN RELEASE; RAT;

EID: 0031738018     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8500     Document Type: Article

References (40)

1. Adlercreutz, H., Markkanen, H., and Watanabe, S. (1993). Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
2. Anderson, E. (1997). Analysis of over-expressed estrogen receptor to consensus and half-site estrogen responsive elements. PhD Thesis, pp. 30-38. University of Wisconsin, Madison.
3. Barnes, S., Peterson, G. T., and Coward, L. (1995). Rational for the use of genistein-containing soy matrices in the chemoprevention trails for breast and prostate cancer. J. Cell. Biochem. 22, 181-187.
4. Cheng, Y., and Prusoff, W. H. (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which couses 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
5. Chun, T.-Y., Gregg, D., Sarkar, D., and Gorski, J. (1998). Differential regulation by estrogens of growth and prolactin synthesis in piruitary cells suggests only a small pool of estrogen receptor is required for growth. Proc. Natl. Acad. Sci. USA 95, 2325-2330.
6. Day, R. N., Koike, S., Sakai, M., Muramatsu, M., and Maurer, R. A. (1990). Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol. Endocrinol. 4, 1964-1971.
7. Elliston, J. F., Fawell, S. E., Klein, H. L., Tsai, S. Y., Tsai, M. J., Parker, M. G., and O'Malley, B. W. (1990). Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol. Cell. Biol. 10, 6607-6612.
8. Foekens, J. A., Henkelman, M. S., Fukkink, J. F., and Blankenstein, M. A. (1986). Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro. Biochem. Biophys. Res. Commun. 140, 550-556.
9. Fritsch, M., Leary, C. M., Furlow, J. D., Ahrens, H., Schuh, T. J., Mueller, G. C., and Gorski, J. (1992). A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31, 5305-5311.
10. Gehm, B. D., McAndrews, J. M., Chien, P.-Y., and Jameson, L. J. (1997). Resveratrol, a polphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94, 14138-14143.
11. Glass, C. K. (1994). Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15, 391-407.
12. Gorski, J., Furlow, J. D., Murdoch, F. E., Fritsch, M., Kaneko, K., Ying, C., and Malayer, J. R. (1993). Perturbations in the model of estrogen receptor regulation of gene expression. Biol. Reprod. 48, 8-14.
13. Gorski, J., Wendell, D., Gregg, D., and Chun, T.-Y. (1997). Estrogens and the genetic control of tumor growth. In Progress in Clinical and Biological Research, Vol. 396, pp. 233-243. Etiology of Breast and Gynecological Cancers (C. M. Aldaz, M. N. Gould, J. McLachlan, and T. J. Slaga, Eds.) Wiley-Liss, New York.
14. Gray, W. G. N., Biswas, E. E., Bashirelahi, N. B., and Biswas, S. B. (1994). A low-affinity estrogen binding site in pregnant rat uteri: Analysis and partial purification. Proc. Natl. Acad. Sci. USA 91, 11502-11506.
15. Harpold, M., Evans, R., Saltditt-Georgieff, M., and Darnell, J. (1979). Production of mRNA in Chinese hamster cells: Relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell 17, 1025-1035.
16. Hoffman, L. M., Fritsch, M. K., and Gorski, J. (1981). Probable nuclear precursors of preprolactin mRNA in rat pituitary. J. Biol. Chem. 256, 2597-2600.
17. Hoffman, R. (1995). Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: Comparison with genistein. Biochem. Biophys. Res. Commun. 211, 600-606.
18. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. S., Fornsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and John, M. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Washington, D.C.) 275, 218-221.
19. Knight, D. C., and Eden, J. A. (1995). Phytoestrogens - A short review. Maturitas 22, 167-175.
20. Knight, D. C., and Eden, J. A. (1996). A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87, 897-904.
21. Makela, S., Davis, V. L., Tally, W. C., Korkman, J., Salo, L., Vihko, R., Santti, R., and Korach, K. S. (1994). Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in culture breast cancer cells. Environ. Health Perspect. 102, 572-578.
22. Makela, S. I., Pylkkanen, L. H., Santti, R. S., and Adlercreutz, H. (1995). Dietary soybean may be anti-estrogenic in male mice. J. Nutr. 125, 437-445.
23. Medlock, K. L., Branham, W. S., and Sheehan, D. M. (1995a). Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc. Soc. Exp. Biol. Med. 208, 67-71.
24. Medlock, K. L., Branham, W. S., and Sheehan, D. M. (1995b). The effects of phytoestrogens on neonatal rat uterine growth and development. Proc. Soc. Exp. Biol. Med. 208, 307-312.
25. Messina, M. J., Persky, V., Setchell, K. D., and Barnes, S. (1994). Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer 21, 113-131.
26. Miksicek, R. J. (1994). Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49, 153-160.
27. Moore, M., Mustain, M., Daniel, K., Chen, I., Safe, S., Zacharewski, T., Billesby, B., Joyeux, A., and Balaguer, P. (1997). Antiestrogenic activity of hydroxylated polychlorinated bisphenol congeners identified in human serum. Toxicol. Appl. Pharmacol. 142: 160-168.
28. Munson, P. J. (1984). Heterogeneous receptors and binding analysis on neurobiology. In Brain Receptor Methodologies (P. J. Maranbos, I. C. Campbell, and R. H. Cohen, Eds.) Academic Press, Orlando.
29. Murdoch, F. E., Grunwald, K. A. A., and Gorski, J. (1991). Marked effects of salt on estrogen receptor binding to DNA: Biologically relevant discrimination between DNA sequences. Biochemistry 30, 10838-10844.
30. Peterson, G., and Barnes, S. (1991). Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 179, 661-667.
31. Ramamoorthy, K., Wang, F., Chen, I., Norris, J., McDonnell, D., Lenonard, L., Gaido, K., Bocchinfuso, W., Korach, K., and Safe, S. (1997). Eestrogeni activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 hyman breast cancer cells, and yeast-base estrogen receptor assay: No apparent synergism. Endocrinology 138: 1520-1527.
32. Scully, K. M., Gleiberman, A. S., Lindzey, J., Lubahn, D. B., Korach, K. S., and Rosenfeld, M. G. (1997). Role of estrogen receptor-α in the anterior pituitary gland. Mol. Endocrinol. 11, 674-681.
33. Seyfred, M. A., and Gorski, J. (1990). An interaction between the 5′ flanking distal and proximal regulatory domains of the rat prolactin gene is required for transcriptional activation by estrogens. Mol. Endocrinol. 4, 1226-1234.
34. Walent, J. H., and Gorski, J. (1990). Estrogen binding is a noncooperative process in primary rat uterine cells. Endocrinology 126, 2383-2391.
35. Wang, H., and Murphy, P. (1994). Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 42, 1666-1673.
36. Wang, T. T. Y., Sathyamoorthy, N., and Phang, J. M. (1996). Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17, 271-275.
37. Whitten, P. L., and Naftolin, F. (1992). Effects of a phytoestrogen diet on estrogen-dependent reproductive processes in immature female rats. Steroids 57, 56-61.
38. Whitten, P. L., Russell, E., and Naftolin, F. (1994). Influence of phytoestrogen diets on estradiol action in the uterus. Steroids 59, 443-449.
39. Wiklund, J., Wertz, N., and Gorski, J. (1981). A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109, 1700-1707.
40. Xu, X., Wang, H.-J., Murphy, P., Cook, L., and Hendrich, S. (1994). Daidzein is more bioacailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124, 825-832.